Research ArticleArticle
Metabolism and Disposition of Vilanterol, a Long-Acting β2-Adrenoceptor Agonist for Inhalation Use in Humans
Andrew W. Harrell, Sarah K. Siederer, Jo Bal, Nainesh H. Patel, Graeme C. Young, Clive C. Felgate, Sebastian J. Pearce, Andy D. Roberts, Claire Beaumont, Amanda J. Emmons, Adrian I. Pereira and Rodger D. Kempsford
Drug Metabolism and Disposition January 2013, 41 (1) 89-100; DOI: https://doi.org/10.1124/dmd.112.048603
Andrew W. Harrell
Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development, Ware, Hertfordshire, United Kingdom (A.W.H., N.H.P., G.C.Y., C.C.F., S.J.P., A.D.R., C.B., A.I.P.); Clinical Pharmacology or Medicines Discovery Research, GlaxoSmithKline Research and Development Ltd., Stevenage, Hertfordshire, United Kingdom (A.J.E., S.K.S., R.D.K.); and Medicines Discovery and Development, GlaxoSmithKline Research and Development, Stockley Park, Middlesex, United Kingdom (J.B.)
Sarah K. Siederer
Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development, Ware, Hertfordshire, United Kingdom (A.W.H., N.H.P., G.C.Y., C.C.F., S.J.P., A.D.R., C.B., A.I.P.); Clinical Pharmacology or Medicines Discovery Research, GlaxoSmithKline Research and Development Ltd., Stevenage, Hertfordshire, United Kingdom (A.J.E., S.K.S., R.D.K.); and Medicines Discovery and Development, GlaxoSmithKline Research and Development, Stockley Park, Middlesex, United Kingdom (J.B.)
Jo Bal
Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development, Ware, Hertfordshire, United Kingdom (A.W.H., N.H.P., G.C.Y., C.C.F., S.J.P., A.D.R., C.B., A.I.P.); Clinical Pharmacology or Medicines Discovery Research, GlaxoSmithKline Research and Development Ltd., Stevenage, Hertfordshire, United Kingdom (A.J.E., S.K.S., R.D.K.); and Medicines Discovery and Development, GlaxoSmithKline Research and Development, Stockley Park, Middlesex, United Kingdom (J.B.)
Nainesh H. Patel
Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development, Ware, Hertfordshire, United Kingdom (A.W.H., N.H.P., G.C.Y., C.C.F., S.J.P., A.D.R., C.B., A.I.P.); Clinical Pharmacology or Medicines Discovery Research, GlaxoSmithKline Research and Development Ltd., Stevenage, Hertfordshire, United Kingdom (A.J.E., S.K.S., R.D.K.); and Medicines Discovery and Development, GlaxoSmithKline Research and Development, Stockley Park, Middlesex, United Kingdom (J.B.)
Graeme C. Young
Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development, Ware, Hertfordshire, United Kingdom (A.W.H., N.H.P., G.C.Y., C.C.F., S.J.P., A.D.R., C.B., A.I.P.); Clinical Pharmacology or Medicines Discovery Research, GlaxoSmithKline Research and Development Ltd., Stevenage, Hertfordshire, United Kingdom (A.J.E., S.K.S., R.D.K.); and Medicines Discovery and Development, GlaxoSmithKline Research and Development, Stockley Park, Middlesex, United Kingdom (J.B.)
Clive C. Felgate
Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development, Ware, Hertfordshire, United Kingdom (A.W.H., N.H.P., G.C.Y., C.C.F., S.J.P., A.D.R., C.B., A.I.P.); Clinical Pharmacology or Medicines Discovery Research, GlaxoSmithKline Research and Development Ltd., Stevenage, Hertfordshire, United Kingdom (A.J.E., S.K.S., R.D.K.); and Medicines Discovery and Development, GlaxoSmithKline Research and Development, Stockley Park, Middlesex, United Kingdom (J.B.)
Sebastian J. Pearce
Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development, Ware, Hertfordshire, United Kingdom (A.W.H., N.H.P., G.C.Y., C.C.F., S.J.P., A.D.R., C.B., A.I.P.); Clinical Pharmacology or Medicines Discovery Research, GlaxoSmithKline Research and Development Ltd., Stevenage, Hertfordshire, United Kingdom (A.J.E., S.K.S., R.D.K.); and Medicines Discovery and Development, GlaxoSmithKline Research and Development, Stockley Park, Middlesex, United Kingdom (J.B.)
Andy D. Roberts
Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development, Ware, Hertfordshire, United Kingdom (A.W.H., N.H.P., G.C.Y., C.C.F., S.J.P., A.D.R., C.B., A.I.P.); Clinical Pharmacology or Medicines Discovery Research, GlaxoSmithKline Research and Development Ltd., Stevenage, Hertfordshire, United Kingdom (A.J.E., S.K.S., R.D.K.); and Medicines Discovery and Development, GlaxoSmithKline Research and Development, Stockley Park, Middlesex, United Kingdom (J.B.)
Claire Beaumont
Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development, Ware, Hertfordshire, United Kingdom (A.W.H., N.H.P., G.C.Y., C.C.F., S.J.P., A.D.R., C.B., A.I.P.); Clinical Pharmacology or Medicines Discovery Research, GlaxoSmithKline Research and Development Ltd., Stevenage, Hertfordshire, United Kingdom (A.J.E., S.K.S., R.D.K.); and Medicines Discovery and Development, GlaxoSmithKline Research and Development, Stockley Park, Middlesex, United Kingdom (J.B.)
Amanda J. Emmons
Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development, Ware, Hertfordshire, United Kingdom (A.W.H., N.H.P., G.C.Y., C.C.F., S.J.P., A.D.R., C.B., A.I.P.); Clinical Pharmacology or Medicines Discovery Research, GlaxoSmithKline Research and Development Ltd., Stevenage, Hertfordshire, United Kingdom (A.J.E., S.K.S., R.D.K.); and Medicines Discovery and Development, GlaxoSmithKline Research and Development, Stockley Park, Middlesex, United Kingdom (J.B.)
Adrian I. Pereira
Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development, Ware, Hertfordshire, United Kingdom (A.W.H., N.H.P., G.C.Y., C.C.F., S.J.P., A.D.R., C.B., A.I.P.); Clinical Pharmacology or Medicines Discovery Research, GlaxoSmithKline Research and Development Ltd., Stevenage, Hertfordshire, United Kingdom (A.J.E., S.K.S., R.D.K.); and Medicines Discovery and Development, GlaxoSmithKline Research and Development, Stockley Park, Middlesex, United Kingdom (J.B.)
Rodger D. Kempsford
Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development, Ware, Hertfordshire, United Kingdom (A.W.H., N.H.P., G.C.Y., C.C.F., S.J.P., A.D.R., C.B., A.I.P.); Clinical Pharmacology or Medicines Discovery Research, GlaxoSmithKline Research and Development Ltd., Stevenage, Hertfordshire, United Kingdom (A.J.E., S.K.S., R.D.K.); and Medicines Discovery and Development, GlaxoSmithKline Research and Development, Stockley Park, Middlesex, United Kingdom (J.B.)
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleArticle
Metabolism and Disposition of Vilanterol in Human
Andrew W. Harrell, Sarah K. Siederer, Jo Bal, Nainesh H. Patel, Graeme C. Young, Clive C. Felgate, Sebastian J. Pearce, Andy D. Roberts, Claire Beaumont, Amanda J. Emmons, Adrian I. Pereira and Rodger D. Kempsford
Drug Metabolism and Disposition January 1, 2013, 41 (1) 89-100; DOI: https://doi.org/10.1124/dmd.112.048603
Research ArticleArticle
Metabolism and Disposition of Vilanterol in Human
Andrew W. Harrell, Sarah K. Siederer, Jo Bal, Nainesh H. Patel, Graeme C. Young, Clive C. Felgate, Sebastian J. Pearce, Andy D. Roberts, Claire Beaumont, Amanda J. Emmons, Adrian I. Pereira and Rodger D. Kempsford
Drug Metabolism and Disposition January 1, 2013, 41 (1) 89-100; DOI: https://doi.org/10.1124/dmd.112.048603
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement